Merck & Co. Total Non Current Liabilities 2011-2026 | MRK

Annual Total Non Current Liabilities Merck & Co.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	36.2 B	33.5 B	34.7 B	37.9 B	37.8 B	30.8 B	35.5 B	32.3 B	31.9 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
37.9 B	30.8 B	34.5 B

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.66	1.14 %	$ 1.01 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.9	-0.2 %	$ 6.62 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 22.33	1.66 %	$ 3.7 B	USA
Esperion Therapeutics ESPR	355 M	$ 1.94	1.31 %	$ 403 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Galectin Therapeutics GALT	52 K	$ 2.38	2.33 %	$ 152 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Greenwich LifeSciences GLSI	9.5 M	$ 24.07	-0.58 %	$ 313 M	USA
Heron Therapeutics HRTX	14.6 M	$ 1.18	-0.84 %	$ 197 M	USA
ImmuCell Corporation ICCC	11.5 M	$ 8.26	-1.07 %	$ 74.6 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
InflaRx N.V. IFRX	254 K	$ 1.61	8.78 %	$ 152 M	Germany
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Innate Pharma S.A. IPHA	105 M	$ 1.39	0.72 %	$ 235 M	France
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Inventiva S.A. IVA	13.8 M	$ 5.11	-0.78 %	$ 138 M	France
Jaguar Health JAGX	10.3 M	$ 0.29	-25.25 %	$ 676 K	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
KalVista Pharmaceuticals KALV	5.05 M	$ 19.09	-2.75 %	$ 1.03 B	Britain
BioNTech SE BNTX	341 M	$ 102.36	-2.94 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.11	0.61 %	$ 439 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 23.18	-0.34 %	$ 2.95 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	50.6 M	$ 1.43	-0.7 %	$ 381 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
Ligand Pharmaceuticals Incorporated LGND	711 M	$ 240.72	4.09 %	$ 4.4 B	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Eli Lilly and Company LLY	50.7 B	$ 874.81	-1.06 %	$ 785 B	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA